Loading clinical trials...
Loading clinical trials...
A Phase I, Multicenter, Open-label Study of SHR-1702 in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions
Interventions
SHR-1702
Locations
1
China
Blood disease hospital of Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China
Start Date
September 10, 2020
Primary Completion Date
February 28, 2023
Completion Date
February 28, 2023
Last Updated
August 24, 2023
NCT03520647
NCT06859424
NCT06994676
NCT07450872
NCT06158828
NCT04645199
Lead Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions